The latest trading session saw Medtronic (MDT) ending at $87.72, denoting a -0.45% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, ...

Minneapolis, Minnesota-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Newspaper coverage, including from the Pioneer Press, after the 1957 blackout. (Courtesy of Medtronic) “Thursday’s power ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

A former Medtronic consultant received an 18-month prison sentence this week for his role in a scheme linked to the $1.6 billion acquisition of an Israeli medical device company in 2018.

Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...

Medtronic (NYSE:MDT) today announced new, long-term study data further supporting its Symplicity Spyral renal denervation ...

Ping An Healthcare and Technology Company Limited established a strategic partnership with Medtronic (MDT) Management Co., Ltd. at the 7th ...

Medtronic, a global leader in healthcare technology, unveiled results from the Prospective Registry for Assessment of Acute ...